Goldschmidt M C, Bodey G P
Antimicrob Agents Chemother. 1972 Apr;1(4):348-53. doi: 10.1128/AAC.1.4.348.
Attempting to explain the predominance of Pseudomonas in leukemic patients, five of the most common gram-negative organisms isolated from sites of infection in cancer patients were exposed to several of the chemotherapeutic agents used in the treatment of this disease (methotrexate, cytosine arabinoside, cyclophosphamide, and 6-mercaptopurine). At concentrations of 125 mug/ml or higher, methotrexate inhibited all organisms except Pseudomonas. Cytosine arabinoside inhibited Escherichia and Klebsiella but appeared to stimulate the growth of Pseudomonas slightly at the higher concentrations. Thus, significant differences existed in individual susceptibilities to these agents. Clinical isolates were more resistant than the corresponding laboratory strains not previously exposed to these compounds. The resistance of Escherichia coli to cyclophosphamide was decreased 26% when it was grown in mixed culture with Pseudomonas. Only Pseudomonas was resistant to all of these compounds whether in pure or mixed culture. These observations may help to explain, in part, the predominant role that Pseudomonas plays as an infectious agent in leukemic patients.
为了解释假单胞菌在白血病患者中占优势的原因,从癌症患者感染部位分离出的5种最常见的革兰氏阴性菌被暴露于治疗该疾病所用的几种化疗药物(甲氨蝶呤、阿糖胞苷、环磷酰胺和6-巯基嘌呤)中。在浓度为125微克/毫升或更高时,甲氨蝶呤抑制了除假单胞菌外的所有细菌。阿糖胞苷抑制了大肠杆菌和克雷伯菌,但在较高浓度下似乎略微刺激了假单胞菌的生长。因此,这些细菌对这些药物的个体敏感性存在显著差异。临床分离株比未接触过这些化合物的相应实验室菌株更具耐药性。当大肠杆菌与假单胞菌混合培养时,其对环磷酰胺的耐药性降低了26%。无论在纯培养还是混合培养中,只有假单胞菌对所有这些化合物都具有耐药性。这些观察结果可能有助于部分解释假单胞菌在白血病患者中作为感染病原体所起的主要作用。